Necrobiosis lipoidica: a rare clinical and pathomorphological case

Main Article Content

Z.P. Nizhynska-Astapenko
M.V. Vlasenko
V.S. Vernygorodsky
L.P. Kholod
O.V. Shvedka


According to modern scientific researches, necrobiosis lipoidica (NL) is a disease characterized by focal disorganization and lipid collagen dystrophy. It is believed that the basis of skin changes in this dermatosis is diabetic microangiopathy that is accompanied by sclerosis and obliteration of blood vessels, which leads to necrobiosis with subsequent deposition of lipids in the dermis. This pathology is registered relatively rarely, in 1 % of patients with diabetes mellitus (DM) on average. The combination of NL with DM, according to the literature data, ranges from 25 to 70 %; more often (in 40–60 % of cases) DM is preceded by NL, and in 10–25 % of cases they occur simultaneously. In addition, in 10–50 % of cases NL is diagnosed in people without concomitant diabetes. The variability of clinical, epidemiological features and the relatively low prevalence of this pathology is often the cause for misdiagnosis or late diagnosis. The described clinical case is typical in terms of the epidemiological data: sex, age, presence of DM. At the same time, it is rare in terms of the clinical picture: it is not classically diabetic by localization (symmetrical areas of the legs are typical), by appearance of necrobiosis areas — granulomatous type of necrobiosis in the form of granuloma annulare, by histological structure — area of chronic perivascular lymphoplasmocytic inflammation with the involvement of single giant cells, which required additional clinical and anamnestic data for an objective report of the pathologist. Biopsy in this case was used as a differential diagnosis between granuloma annulare and necrobiotic necrogranuloma. In addition, this method of diagnosis has played an additional therapeutic role. This case may have demonstrated the activation of the cellular and humoral immune response in the area of chronic inflammation in response to a mechanical damage and the resolution of inflammation with complete tissue repair.

Article Details

How to Cite
Nizhynska-Astapenko, Z., M. Vlasenko, V. Vernygorodsky, L. Kholod, and O. Shvedka. “Necrobiosis Lipoidica: A Rare Clinical and Pathomorphological Case”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 17, no. 8, Jan. 2022, pp. 651-5, doi:10.22141/2224-0721.17.8.2021.246882.
Clinical Case


Feily A, Mehraban S. Treatment Modalities of Necrobiosis Lipoidica: A Concise Systematic Review. Dermatol Reports. 2015 Jun 8;7(2):5749. doi: 10.4081/dr.2015.5749.

Semenova DA, Tokmakova AYu. Necrobiosis lipoidica in diabetic patients: pathogenetic and clinical features. Diabetes mellitus. 2011;14(4):51-54.  doi: 10.14341/2072-0351-5817. (In Russian).

Mistry BD, Alavi A, Ali S, Mistry N. A systematic review of the relationship between glycemic control and necrobiosis lipoidica diabeticorum in patients with diabetes mellitus. Int J Dermatol. 2017 Dec;56(12):1319-1327. doi: 10.1111/ijd.13610.

Fehlman JA, Burkemper NM, Missall TA. Ulcerative necrobiosis lipoidica in the setting of anti-tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis. JAAD Case Rep. 2017 Mar 12;3(2):127-130. doi: 10.1016/j.jdcr.2017.01.006.

Reid SD, Ladizinski B, Lee K, Baibergenova A, Alavi A. Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options. J Am Acad Dermatol. 2013 Nov;69(5):783-791. doi: 10.1016/j.jaad.2013.05.034.

Hammer E, Lilienthal E, Hofer SE, Schulz S, Bollow E, Holl RW; DPV Initiative and the German BMBF Competence Network for Diabetes Mellitus. Risk factors for necrobiosis lipoidica in Type 1 diabetes mellitus. Diabet Med. 2017 Jan;34(1):86-92. doi: 10.1111/dme.13138.

Erfurt-Berge C, Dissemond J, Schwede K, et al. Updated results of 100 patients on clinical features and therapeutic options in necrobiosis lipoidica in a retrospective multicentre study. Eur J Dermatol. 2015 Nov-Dec;25(6):595-601. doi: 10.1684/ejd.2015.2636.

Hashemi DA, Nelson CA, Elenitsas R, Rosenbach M. An atypical case of papular necrobiosis lipoidica masquerading as sarcoidosis. JAAD Case Rep. 2018 Sep 14;4(8):802-804. doi: 10.1016/j.jdcr.2018.07.011.

Pourang A, Sivamani RK. Treatment-resistant ulcerative necrobiosis lipoidica in a diabetic patient responsive to ustekinumab. Dermatol Online J. 2019 Aug 15;25(8):13030/qt2q05z4rw.

Most read articles by the same author(s)

1 2 > >>